Ann: Trading Halt, page-77

livewire

https://www.livewiremarkets.com/wires/the-new-criterion-all-the-dope-on-emerald-clinics-limp-debut

Emerald also has a tie-up with listed pot stock Zelira (formerly Zelda) Therapeutics, in view of Zelira accessing data for patients treated with pain and insomnia.Washer says the insurers are highly receptive to reimbursing the drugs that are proven to work, especially when they are an alternative to opioids for conditions such as chronic back pain. It’s no coincidence the board includes the British clinician Sir John Tooke, who sat on the board of the health insurance giant BUPA......